QYE · Class II · 21 CFR 870.2380

FDA Product Code QYE: Reduced Ejection Fraction Machine Learning-based Notification Software

Reduced Ejection Fraction Machine Learning-based Notification Software Employs Machine Learning Techniques To Suggest The Likelihood Of A Reduced Ejection Fraction For Further Referral Or Diagnostic Follow-up.

Leading manufacturers include Anumana, Inc., Eko Health, Inc. and Tempus AI, Inc..

5
Total
5
Cleared
144d
Avg days
2023
Since
Growing category - 3 submissions in the last 2 years vs 2 in the prior period
Review times increasing: avg 175d recently vs 99d historically

FDA 510(k) Cleared Reduced Ejection Fraction Machine Learning-based Notification Software Devices (Product Code QYE)

5 devices
1–5 of 5

About Product Code QYE - Regulatory Context

510(k) Submission Activity

5 total 510(k) submissions under product code QYE since 2023, with 5 receiving FDA clearance (average review time: 144 days).

Submission volume has increased in recent years - 3 submissions in the last 24 months compared to 2 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under QYE have taken an average of 175 days to reach a decision - up from 99 days historically. Manufacturers should account for longer review timelines in current project planning.

QYE devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →